Related Experiment Videos
Recent advances in drug-induced neuropathies
Amanda C Peltier1, James W Russell
1Department of Neurology, University of Michigan, Ann Arbor, Michigan 48109, USA.
Current Opinion in Neurology
|September 28, 2002
Summary
Medications for cancer, HIV, and transplant rejection can cause peripheral neuropathy. Understanding cellular mechanisms and early diagnosis helps manage drug-induced nerve damage.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- Peripheral neuropathy is a common side effect of medications used for critical illnesses.
- Balancing therapeutic benefits with neurotoxic effects is challenging.
Purpose of the Study:
- To review recent research on cellular mechanisms of drug-induced peripheral neuropathy.
- Focus on medications for cancer, HIV, and transplant rejection.
Main Methods:
- Review of current scientific literature on drug-induced neuropathy.
- Analysis of cellular mechanisms, including apoptosis, mitochondrial dysfunction, and demyelination.
Main Results:
- Cisplatin and suramin cause axonal neuropathy via dorsal root ganglion neuron apoptosis.
- Nucleoside reverse transcriptase inhibitors impact mitochondrial DNA.
- Tacrolimus and suramin can induce demyelinating neuropathy.
- Nerve growth factor, glutamine, IVIg, and plasmapheresis show potential therapeutic benefits.
Conclusions:
- Understanding neurotoxic mechanisms is key to managing peripheral neuropathy.
- Early diagnosis and targeted therapies can mitigate drug-induced nerve damage.